NCAB Puts 20% Cap On P01 Budget Raises To Stem Requests Exceeding NCI’s.
Bishop Completes Term As NCAB Chairman; Terms Of Five Extended Awaiting W.H. Action.
UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.
NCI, SAIC To Support Contracts For Molecular Target Labs.
NCAB: An Extraordinary Opportunity For Budgetary Coordination.
Aetna No Longer To Cover HDC/BMT For Breast Cancer Outside Of Clinical Trials.
BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.
Aventis, MediGene In Pact For Development Of Vaccine.
Firm To Study Imaging System As Adjunct To Mammogram.
Techniclone Wins Patent For Tumor Necrosis Therapy.
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
